Yoon et al., 2024 - Google Patents
Rational approach to improve detergent efficacy for membrane protein stabilizationYoon et al., 2024
View HTML- Document ID
- 10139096906759724895
- Author
- Yoon S
- Bae H
- Hariharan P
- Nygaard A
- Lan B
- Woubshete M
- Sadaf A
- Liu X
- Loland C
- Byrne B
- Guan L
- Chae P
- Publication year
- Publication venue
- Bioconjugate chemistry
External Links
Snippet
Membrane protein structures are essential for the molecular understanding of diverse cellular processes and drug discovery. Detergents are not only widely used to extract membrane proteins from membranes but also utilized to preserve native protein structures in …
- 108010052285 Membrane Proteins 0 title abstract description 385
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ehsan et al. | Highly branched pentasaccharide-bearing amphiphiles for membrane protein studies | |
| Guha et al. | Mechanistic landscape of membrane-permeabilizing peptides | |
| Yoon et al. | Rational approach to improve detergent efficacy for membrane protein stabilization | |
| Wiedman et al. | pH-triggered, macromolecule-sized poration of lipid bilayers by synthetically evolved peptides | |
| Egloff et al. | Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli | |
| Nath et al. | Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins | |
| Daudey et al. | Membrane-fusogen distance is critical for efficient coiled-coil-peptide-mediated liposome fusion | |
| Das et al. | Conformationally preorganized diastereomeric norbornane-based maltosides for membrane protein study: Implications of detergent kink for micellar properties | |
| Ouyang et al. | Recent advances of studies on cell-penetrating peptides based on molecular dynamics simulations | |
| Kabelka et al. | Selecting collective variables and free-energy methods for peptide translocation across membranes | |
| CN101939329A (en) | Amino Acid Pairing-Based Self-Assembling Peptides and Methods | |
| WO2014076655A1 (en) | Polypeptides for blood brain barrier transport | |
| Ehsan et al. | New Malonate-derived tetraglucoside detergents for membrane protein stability | |
| Fledderman et al. | Myristate exposure in the human immunodeficiency virus type 1 matrix protein is modulated by pH | |
| Sadaf et al. | Conformationally restricted monosaccharide-cored glycoside amphiphiles: the effect of detergent headgroup variation on membrane protein stability | |
| Kamilar et al. | SMALPs are not simply nanodiscs: the polymer-to-lipid ratios of fractionated SMALPs underline their heterogeneous nature | |
| Das et al. | Diastereomeric cyclopentane-based maltosides (CPMs) as tools for membrane protein study | |
| Milogrodzka et al. | Effect of cholesterol on biomimetic membrane curvature and coronavirus fusion peptide encapsulation | |
| Ghani et al. | 1, 3, 5-Triazine-cored maltoside amphiphiles for membrane protein extraction and stabilization | |
| Ghani et al. | Tris (hydroxymethyl) aminomethane Linker-Bearing Triazine-Based Triglucosides for Solubilization and Stabilization of Membrane Proteins | |
| Khayyatnejad Shoushtari et al. | Hybrid cyclic-linear cell-penetrating peptides containing alternative positively charged and hydrophobic residues as molecular transporters | |
| Lundstrom et al. | G protein-coupled receptors in drug discovery | |
| Povilaitis et al. | Design of peptides for membrane insertion: The critical role of charge separation | |
| Missirlis et al. | Linker Chemistry determines secondary structure of p5314− 29 in peptide amphiphile micelles | |
| Naider et al. | A paradigm for peptide hormone-GPCR analyses |